Effects of antihypertensive therapy on platelet cytosolic calcium responses to low density lipoprotein cholesterol

J. R. Sowers, B. B. Raman, L. C. Afonso, K. Bedford-Rice, Paul R Standley

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

This study examines the effects of antihypertensive therapy on platelet cytosolic calcium [Ca2+](i) responses to low-density lipoprotein cholesterol (LDL) and vasopressin (AVP) in 15 patients (50-80 years) participating in the Hypertension Optimal Treatment International Study. All patients (diastolic blood pressure (DBP) ≥ 100 mm Hg and ≤ 115 mm Hg) were treated with the calcium antagonist felodipine (10 mg po) with or without addition of enalapril (up to 20 mg daily as needed) to lower diastolic pressures to < 85 mm Hg. This antihypertensive therapy lowered DBP (104 ± 0.8 to 78 ± 1.6 mm Hg, P < 0.0001), but had no effect on basal [Ca2+](i) or AVP-stimulated [Ca2+], responses. Basal platelet [Ca2+], following antihypertensive therapy (49 ± 3.4 ng/ml) were not different from those prior to therapy (52 ± 4.7 ng/ml). Additionally, [Ca2+], responses to AVP following therapy (554 ± 74 units) were not different from those prior to treatment (595 ± 49 units). Following antihypertensive therapy, [Ca2+], responses to 200 μg/ml of LDL were decreased fourfold (P < 0.05). These results suggest that anithypertensive therapy with a calcium channel blocker may potentially impact the atherogenic process by reducing the platelet [Ca2+](i) rise, and potentially the aggregatory response, to LDL.

Original languageEnglish (US)
Pages (from-to)177-180
Number of pages4
JournalJournal of Human Hypertension
Volume10
Issue number3
StatePublished - Mar 1996
Externally publishedYes

Fingerprint

LDL Cholesterol
Antihypertensive Agents
Blood Platelets
Calcium
Blood Pressure
Vasopressins
Therapeutics
Felodipine
Enalapril
Calcium Channel Blockers
Hypertension

Keywords

  • LDL-cholesterol
  • Platelet cytosolic calcium

ASJC Scopus subject areas

  • Internal Medicine

Cite this

Effects of antihypertensive therapy on platelet cytosolic calcium responses to low density lipoprotein cholesterol. / Sowers, J. R.; Raman, B. B.; Afonso, L. C.; Bedford-Rice, K.; Standley, Paul R.

In: Journal of Human Hypertension, Vol. 10, No. 3, 03.1996, p. 177-180.

Research output: Contribution to journalArticle

Sowers, J. R. ; Raman, B. B. ; Afonso, L. C. ; Bedford-Rice, K. ; Standley, Paul R. / Effects of antihypertensive therapy on platelet cytosolic calcium responses to low density lipoprotein cholesterol. In: Journal of Human Hypertension. 1996 ; Vol. 10, No. 3. pp. 177-180.
@article{322ca129fd254a93af960df88a9b65fb,
title = "Effects of antihypertensive therapy on platelet cytosolic calcium responses to low density lipoprotein cholesterol",
abstract = "This study examines the effects of antihypertensive therapy on platelet cytosolic calcium [Ca2+](i) responses to low-density lipoprotein cholesterol (LDL) and vasopressin (AVP) in 15 patients (50-80 years) participating in the Hypertension Optimal Treatment International Study. All patients (diastolic blood pressure (DBP) ≥ 100 mm Hg and ≤ 115 mm Hg) were treated with the calcium antagonist felodipine (10 mg po) with or without addition of enalapril (up to 20 mg daily as needed) to lower diastolic pressures to < 85 mm Hg. This antihypertensive therapy lowered DBP (104 ± 0.8 to 78 ± 1.6 mm Hg, P < 0.0001), but had no effect on basal [Ca2+](i) or AVP-stimulated [Ca2+], responses. Basal platelet [Ca2+], following antihypertensive therapy (49 ± 3.4 ng/ml) were not different from those prior to therapy (52 ± 4.7 ng/ml). Additionally, [Ca2+], responses to AVP following therapy (554 ± 74 units) were not different from those prior to treatment (595 ± 49 units). Following antihypertensive therapy, [Ca2+], responses to 200 μg/ml of LDL were decreased fourfold (P < 0.05). These results suggest that anithypertensive therapy with a calcium channel blocker may potentially impact the atherogenic process by reducing the platelet [Ca2+](i) rise, and potentially the aggregatory response, to LDL.",
keywords = "LDL-cholesterol, Platelet cytosolic calcium",
author = "Sowers, {J. R.} and Raman, {B. B.} and Afonso, {L. C.} and K. Bedford-Rice and Standley, {Paul R}",
year = "1996",
month = "3",
language = "English (US)",
volume = "10",
pages = "177--180",
journal = "Journal of Human Hypertension",
issn = "0950-9240",
publisher = "Nature Publishing Group",
number = "3",

}

TY - JOUR

T1 - Effects of antihypertensive therapy on platelet cytosolic calcium responses to low density lipoprotein cholesterol

AU - Sowers, J. R.

AU - Raman, B. B.

AU - Afonso, L. C.

AU - Bedford-Rice, K.

AU - Standley, Paul R

PY - 1996/3

Y1 - 1996/3

N2 - This study examines the effects of antihypertensive therapy on platelet cytosolic calcium [Ca2+](i) responses to low-density lipoprotein cholesterol (LDL) and vasopressin (AVP) in 15 patients (50-80 years) participating in the Hypertension Optimal Treatment International Study. All patients (diastolic blood pressure (DBP) ≥ 100 mm Hg and ≤ 115 mm Hg) were treated with the calcium antagonist felodipine (10 mg po) with or without addition of enalapril (up to 20 mg daily as needed) to lower diastolic pressures to < 85 mm Hg. This antihypertensive therapy lowered DBP (104 ± 0.8 to 78 ± 1.6 mm Hg, P < 0.0001), but had no effect on basal [Ca2+](i) or AVP-stimulated [Ca2+], responses. Basal platelet [Ca2+], following antihypertensive therapy (49 ± 3.4 ng/ml) were not different from those prior to therapy (52 ± 4.7 ng/ml). Additionally, [Ca2+], responses to AVP following therapy (554 ± 74 units) were not different from those prior to treatment (595 ± 49 units). Following antihypertensive therapy, [Ca2+], responses to 200 μg/ml of LDL were decreased fourfold (P < 0.05). These results suggest that anithypertensive therapy with a calcium channel blocker may potentially impact the atherogenic process by reducing the platelet [Ca2+](i) rise, and potentially the aggregatory response, to LDL.

AB - This study examines the effects of antihypertensive therapy on platelet cytosolic calcium [Ca2+](i) responses to low-density lipoprotein cholesterol (LDL) and vasopressin (AVP) in 15 patients (50-80 years) participating in the Hypertension Optimal Treatment International Study. All patients (diastolic blood pressure (DBP) ≥ 100 mm Hg and ≤ 115 mm Hg) were treated with the calcium antagonist felodipine (10 mg po) with or without addition of enalapril (up to 20 mg daily as needed) to lower diastolic pressures to < 85 mm Hg. This antihypertensive therapy lowered DBP (104 ± 0.8 to 78 ± 1.6 mm Hg, P < 0.0001), but had no effect on basal [Ca2+](i) or AVP-stimulated [Ca2+], responses. Basal platelet [Ca2+], following antihypertensive therapy (49 ± 3.4 ng/ml) were not different from those prior to therapy (52 ± 4.7 ng/ml). Additionally, [Ca2+], responses to AVP following therapy (554 ± 74 units) were not different from those prior to treatment (595 ± 49 units). Following antihypertensive therapy, [Ca2+], responses to 200 μg/ml of LDL were decreased fourfold (P < 0.05). These results suggest that anithypertensive therapy with a calcium channel blocker may potentially impact the atherogenic process by reducing the platelet [Ca2+](i) rise, and potentially the aggregatory response, to LDL.

KW - LDL-cholesterol

KW - Platelet cytosolic calcium

UR - http://www.scopus.com/inward/record.url?scp=0029863771&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0029863771&partnerID=8YFLogxK

M3 - Article

C2 - 8733036

AN - SCOPUS:0029863771

VL - 10

SP - 177

EP - 180

JO - Journal of Human Hypertension

JF - Journal of Human Hypertension

SN - 0950-9240

IS - 3

ER -